Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > April 7, 2023
Daily News
April 7, 2023
- 9-Valent HPV Vaccine Program Poses Opportunity to Boost Inoculation Rate: LDP Lawmaker
April 7, 2023
- Japan Needs Guidelines on Conditional Approval for Regenerative Medicines: Lawmakers
April 7, 2023
- Tokyo Likely to See Next COVID Spike around First Half of May: Experts
April 7, 2023
- JCR, Sumitomo Sign Copromotion Pact for Izcargo in Japan
April 7, 2023
- Japan Pharma Sales Up 1.3% in FY2022: Encise
April 7, 2023
- Generic Use Rate Hits Record 81.2% in October-December: JGA
April 7, 2023
- Kissei’s ITP Med Tavalisse Now Available in Japan
April 7, 2023
- Major Renovation at Eisai’s Tsukuba Lab Completed
April 7, 2023
- Kowa Kicks Off Another PIII for Ripasudil for Fuchs Endothelial Corneal Dystrophy
April 7, 2023
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…